Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report.
Fiche publication
Date publication
avril 2011
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BORG Christophe, Pr DI MARTINO Vincent, Pr PIVOT Xavier, Dr CURTIT Elsa, Dr THIERY-VUILLEMIN Antoine, Pr HEYD Bruno
Tous les auteurs :
Curtit E, Thiery-Vuillemin A, Nguyen T, Heyd B, Pivot X, Di Martino V, Borg C
Lien Pubmed
Mots clés
Angiogenesis Inhibitors, adverse effects, Benzenesulfonates, adverse effects, Carcinoma, Hepatocellular, drug therapy, Chemotherapy, Adjuvant, Diffusion Magnetic Resonance Imaging, Hepatectomy, Humans, Liver Neoplasms, drug therapy, Male, Middle Aged, Molecular Targeted Therapy, Niacinamide, analogs & derivatives, Phenylurea Compounds, Protein Kinase Inhibitors, adverse effects, Pyridines, adverse effects, Time Factors, Treatment Outcome, alpha-Fetoproteins, metabolism, raf Kinases, antagonists & inhibitors
Référence
J. Clin. Oncol.. 2011 Apr;29(12):e330-2